Primary structure of horse serotransferrin glycans. Demonstration that heterogeneity is related to the number of glycans and to the presence of N-acetylneuraminic acid and N-acetyl-4-O-acetylneuraminic acid.

This study focuses on determining the structure and variability of glycans, or carbohydrates, present in horse serotransferrin, a specific protein involved in iron transport in the bloodstream. The research concludes that variations in the structure of these glycans are responsible for the heterogeneity observed in different variants of this protein.

Key Findings and Methodology

• The focus of the study was on three specific variants of horse serotransferrin: Tf 2a, Tf 4b, and Tf 5b. These were isolated in a pure form from a preparation of homozygous horse serotransferrin Tf 0.
• Based on the results from molecular mass determinations and carbohydrate analyses, the researchers concluded that the Tf 2a variant of serotransferrin contains only one glycan, while the Tf 4b and Tf 5b variants contain two glycans.
• The structure of the glycans was established through a combination of methylation analysis, mass spectrometry, and 400-MHz 1H-NMR spectroscopy. These are all techniques used for identifying and analyzing the physical and chemical properties of molecules.

Differences in Glycan Structures

• The two glycans of the Tf 5b variant were found to be of the N-acetyllactosaminic biantennary type, fully sialylated by two residues of N-acetylneuraminic acid. This was similar to the structure of human serotransferrin glycans.
• In contrast, the Tf 2a and Tf 4b variants showed a different structure. In addition to the N-acetyllactosaminic biantennary structure seen in Tf 5b, two other biantennary structures, named type II-A and type II-B, were identified. These were sialylated by one N-acetylneuraminic acid residue and one N-acetyl-4-O-acetylneuraminic acid residue located at different positions. Additionally, a structure named type III, sialylated by two residues of N-acetyl-4-O-acetylneuraminic acid, was identified in these variants.

Conclusions

• The results from the analyzed serotransferrin samples suggest that the structural differences and the number of glycans attached to the protein chain result in the observed variations among the serotransferrin variants.
• Moreover, despite the identified differences in glycan structures and quantities, not all disparities in the molecular mass of the variants Tf 2a, Tf 4b, and Tf 5b can be explained. This suggests that there might also be differences in the polypeptide chains of these serotransferrin variants that contribute to their unique properties.